Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 5 studies | 19% ± 3% | |
endothelial cell | 4 studies | 18% ± 0% | |
non-classical monocyte | 3 studies | 22% ± 3% | |
astrocyte | 3 studies | 26% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2997.60 | 2642 / 2642 | 100% | 31.03 | 704 / 705 |
kidney | 100% | 2068.53 | 89 / 89 | 100% | 20.79 | 899 / 901 |
ovary | 100% | 1505.53 | 180 / 180 | 100% | 15.49 | 428 / 430 |
esophagus | 100% | 1976.39 | 1442 / 1445 | 99% | 16.55 | 182 / 183 |
thymus | 100% | 1582.04 | 650 / 653 | 99% | 19.11 | 601 / 605 |
uterus | 100% | 1472.39 | 170 / 170 | 99% | 18.68 | 453 / 459 |
breast | 100% | 1333.76 | 457 / 459 | 99% | 15.14 | 1108 / 1118 |
lung | 99% | 1983.67 | 575 / 578 | 98% | 16.07 | 1135 / 1155 |
prostate | 100% | 1592.84 | 244 / 245 | 97% | 11.82 | 488 / 502 |
bladder | 100% | 1721.19 | 21 / 21 | 96% | 14.33 | 485 / 504 |
intestine | 100% | 2203.41 | 964 / 966 | 96% | 12.02 | 508 / 527 |
skin | 99% | 1212.50 | 1787 / 1809 | 96% | 20.25 | 455 / 472 |
adrenal gland | 100% | 1825.56 | 258 / 258 | 93% | 16.80 | 214 / 230 |
stomach | 77% | 974.97 | 276 / 359 | 95% | 11.50 | 272 / 286 |
liver | 82% | 716.71 | 186 / 226 | 74% | 7.02 | 301 / 406 |
pancreas | 41% | 286.48 | 134 / 328 | 98% | 13.10 | 174 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.12 | 29 / 29 |
spleen | 100% | 3128.57 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1767.34 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1676.03 | 1199 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1762.41 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3106.72 | 852 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 19.08 | 44 / 45 |
peripheral blood | 96% | 2879.29 | 888 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 14.67 | 71 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0071539 | Biological process | protein localization to centrosome |
GO_0016607 | Cellular component | nuclear speck |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | TRIM69 |
Protein name | E3 ubiquitin-protein ligase TRIM69 (Tripartite motif containing 69) E3 ubiquitin-protein ligase TRIM69 E3 ubiquitin-protein ligase TRIM69 (EC 2.3.2.27) (RFP-like domain-containing protein trimless) (RING finger protein 36) (RING-type E3 ubiquitin transferase TRIM69) (Tripartite motif-containing protein 69) |
Synonyms | HSD34 HSD-34 RNF36 |
Description | FUNCTION: E3 ubiquitin ligase that plays an important role in antiviral immunity by restricting different viral infections including dengue virus or vesicular stomatitis indiana virus . Ubiquitinates viral proteins such as dengue virus NS3 thereby limiting infection . In addition, acts as a key mediator of type I interferon induced microtubule stabilization by directly associating to microtubules independently of its E3 ligase activity . Plays also a role in cataract formation together with TP53 . Mechanistically, inhibits UVB-induced cell apoptosis and reactive oxygen species (ROS) production by inducing TP53 ubiquitination . Regulates centrosome dynamics and mitotic progression by ubiquitinating STK3/MST2; leading to its redistribution to the perinuclear cytoskeleton and subsequent phosphorylation by PLK1 . . |
Accessions | Q86WT6 ENST00000559390.5 [Q86WT6-1] ENST00000558329.5 [Q86WT6-4] ENST00000560442.5 [Q86WT6-3] H0YKB8 ENST00000621836.3 ENST00000633414.1 ENST00000618398.2 [Q86WT6-2] ENST00000633859.1 ENST00000633106.1 [Q86WT6-3] ENST00000329464.9 [Q86WT6-1] ENST00000561170.1 ENST00000631458.1 H0YL66 ENST00000561043.5 A0A0G2JPI4 ENST00000338264.8 [Q86WT6-2] ENST00000631740.1 [Q86WT6-4] |